10.07.2015 Views

2008 Summer Meeting - Leeds - The Pathological Society of Great ...

2008 Summer Meeting - Leeds - The Pathological Society of Great ...

2008 Summer Meeting - Leeds - The Pathological Society of Great ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

P155How Do Histopathology Trainees Choose their TrainingSchool?SD Preston 1 ,SCossins 1 , RD Liebmann 1 , AH McGregor 11 Histopathology Training Schools Board<strong>The</strong>re is a national appointment process for applicants for histopathologytraining schemes in England and Wales. A combination <strong>of</strong> applicant choice,interview ranking and special circumstances is used to match appointees totraining schools. This increases the best candidates’ chances <strong>of</strong> gaining atraining post, but decreases their control over where they work. <strong>The</strong>geographies <strong>of</strong>fered were related to the Deaneries co-ordinating trainingprogrammes at Yr 2 – 5 level.We surveyed all 1st year Histopathology run-through trainees in England andWales to enquire about the information they used to choose a training school,the factors they considered and their opinions <strong>of</strong> the process.<strong>The</strong> response rate was 78%, most gaining their information from theHistopathology Training Schools’ website. <strong>The</strong> commonest factors in choosinga training school were the location <strong>of</strong> a partner (75%), and the HistopathologyTraining School’s reputation (59%). Children were a factor for 18%, and 24%expressed an interest in research. For 52%, the location <strong>of</strong> their family was themost important factor. Encouragingly, 84% felt that the matching process usedwas fair.Our survey has shown an acceptable matching scheme with a website(histopathsho.34sp.com) which is a valuable resource for applicants. Whilegeography is an important factor, almost a quarter <strong>of</strong> trainees chose theirtraining school, at least in part, because <strong>of</strong> the research opportunities available.This is encouraging for a potential resurgence in histopathology research andunderline the importance <strong>of</strong> the newly created academic pathology trainingposts in many training programmes.P157Intrathyroid lymph node tissue in multinodular goiter, casereport in Egyptian female.AAbdou 1 ,HAiad 11 Pathology Department, Faculty <strong>of</strong> Medicine, Men<strong>of</strong>iya UniversityWe report a case <strong>of</strong> intrathyroid lymph node tissue in 40 years old Egyptianfemale. Collections <strong>of</strong> lymphoid follicles surrounded by mature fat cells wereintimately associated with normal thyroid follicles. <strong>The</strong> presence <strong>of</strong> thisheterotopic tissue could arise by the process <strong>of</strong> heteroplasia or it could be justdeviation <strong>of</strong> the normal anatomy <strong>of</strong> cervical lymph node groups.P156<strong>The</strong> Value <strong>of</strong> One Stop Head and Neck ClinicsV Willis 1 ,VForia 11 Department <strong>of</strong> Cellular Pathology, Southampton General HospitalBackground: One stop head and neck clinics were introduced in response toNICE guidelines 2004 with the aim to provide rapid assessment and provisionaldiagnosis <strong>of</strong> suspected cancer patients. <strong>The</strong>y comprise clinical review followedby ultrasound-guided fine needle aspirate with immediate cytological reportingby the pathologist. At our centre this clinic was established two years ago. <strong>The</strong>aim <strong>of</strong> this audit was to study the impact <strong>of</strong> the ‘One Stop’ method byinvestigating the correlation between clinical impression, radiological findings,cytology and histology reports, and subsequently comparing this data withcases prior to the set up. Methods: FNA and histology reports were collectedfrom approximately 100 patients who had attended the clinic between 2005 and2007. We combined this data with the clinical details and radiology reportsprovided by the surgical team. This information was then analysed andcompared to a similar cohort prior to this set up. Discussion: Our data shows agood overall correlation between FNA cytology and histology reports.Furthermore the number <strong>of</strong> inadequate samples has significantly reduced overthe past two years. In this centre the introduction <strong>of</strong> the one stop head and neckclinic has had a significant impact on management <strong>of</strong> cancer cases by allowingrapid accurate diagnosis and thereby permitting early treatment. In addition, ithas benefited patients through fewer hospital visits, prompt reassurance andreduced anxiety overall.P158Engaging Histopathologists in Pharmaceutical Research andDevelopmentCWomack 1 , SR Morgan 1 , A Hughes 11 AstraZeneca, Alderley Park, Macclesfield, CheshireA major part <strong>of</strong> the practice <strong>of</strong> most histopathologists is to continue to providethe “gold standard” for cancer diagnosis. <strong>The</strong>ir trained observations alsocontribute significantly to information that is linked to prognosis and are usedin cancer therapy planning. Histopathologists can also play an important role inpharmaceutical research and clinical trials though very few are employed fulltimein industry.In our practice we have identified the following areas where application <strong>of</strong>histopathologists’ expertise adds value to the drug discovery process:· Provision <strong>of</strong> the general and specialist, diagnostic and research skills, in basicand molecular pathology used in hospital practice and university laboratories, topharma as “key opinion leaders” and as consultants for individual projects. Thisarea has the greatest potential for public/industry collaborative research.· Histopathologists are custodians <strong>of</strong> tissue that is surplus to diagnosticrequirements that would normally be archived or discarded.· Histopathologists are key to the laboratory collection, processing and review<strong>of</strong> samples taken as part <strong>of</strong> clinical trials as well as allowing access to archivalhuman tissue and pathology data for patient inclusion.· Provision <strong>of</strong> histopathology services to a pharma company as externalconsultants or as employees for histopathological and biomarker analysesincluding the evaluation <strong>of</strong> new technology platforms.In clinical research histopathologists are integral to translational science, forpro<strong>of</strong> <strong>of</strong> mechanism and/or principle, and also play an important role in drugdevelopment in Phase III trials.<strong>Summer</strong> <strong>Meeting</strong> (194 th ) 1–4 July <strong>2008</strong> Scientific Programme71

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!